Navigating the life science maze

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Navigating the life science maze

China's rapidly evolving regulatory framework and its increasingly sophisticated courts offer a bright future to pharmaceutical companies looking to invest in China, says Sofia Chen of Bird & Bird

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login
more from across site and SHARED ros bottom lb

More from across our site

More important FRAND decisions by the UK courts and a changing of the guard for Siemens’ IP team were among the top talking points this week
Gift this article